Cambridge Healthtech Institute’s Inaugural

Precision Medicine

Beyond the Genome for Insights into New Treatments

March 7 – 9, 2016 | Moscone North Convention Center | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference

 

Numerous factors are coalescing to promote the adoption of precision medicine practices around the globe, such as greater statistical power from amassed genetic research, the falling cost of data storage along with the rise of mobile technologies and wide-spread use of electronic health records. The percentage of targeted therapies has been steadily increasing in the total number of drugs approved and is proving to be the way forward. This conference will convene leaders in the precision medicine community to talk about their vision and expertise on how to accelerate biomedical discoveries and enable the accurate diagnosis and treatment of diseases.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Diagnostic and Medical Device companies, large Pharma, Biotechs and Academia working in fields of Diagnostics, Business Development, R&D, Chemistry, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.

Topics will include, but are not limited to:

  • Precision medicine implementation strategies
  • Calculating overall risk of treatment
  • Employing metabolomics with NGS for patient screening
  • Bringing genomics to the physician
  • Developing standards for analysis, interpretation and reporting of clinical genome sequencing results
  • Sharing patient data to achieve statistical power
  • Educating the public on pharmacogenomics testing
  • Discovering candidate genes
  • Improving knowledge extraction from health data to facilitate research
  • Translating genetic information into the discovery and development of new therapies

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 28, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E: clingham@healthtech.com

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com

Premier Sponsors:  

Bina Technologies

Coyote

Elsevier   

Jackson Laboratory - small logo 

 NanoString2   

 Precision for Medicine 

SeraCare(2)

Silicon Biosystems

Thomson Reuters-Large